Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devin Sok

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Plos Pathogens|April 28, 2022
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variantNitin Hingankar, Suprit Deshpande, Payel Das, et al.
Science (New York, N.Y.)|November 2, 2019
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responsesJon M Steichen, Ying-Cing Lin, Colin Havenar-Daughton, et al.
Science Translational Medicine|September 8, 2017
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challengeBoris Julg, Lawrence J Tartaglia, Brandon F Keele, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Virus glycoprotein nanodisc platform for vaccine designKimmo Rantalainen, Alessia Liguori, Gabriel Ozorowski, et al.
Nature Microbiology|November 15, 2016
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerabilityMarit J van Gils, Tom L G M van den Kerkhof, Gabriel Ozorowski, et al.
Nature Communications|August 3, 2022
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoproteinJelle van Schooten, Elinaz Farokhi, Anna Schorcht, et al.
Cell Reports|November 24, 2016
Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env TrimerColin Havenar-Daughton, Diane G Carnathan, Alba Torrents de la Peña, et al.
Plos Pathogens|November 17, 2022
Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizerJelle van Schooten, Anna Schorcht, Elinaz Farokhi, et al.
Nature Communications|September 6, 2022
Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virusFangzhu Zhao, Zachary T Berndsen, Nuria Pedreño-Lopez, et al.
Nature Communications|February 10, 2026
Virus glycoprotein nanodisc platform for vaccine analyticsKimmo Rantalainen, Alessia Liguori, Gabriel Ozorowski, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Plos Pathogens|April 28, 2022
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variantNitin Hingankar, Suprit Deshpande, Payel Das, et al.
Science (New York, N.Y.)|November 2, 2019
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responsesJon M Steichen, Ying-Cing Lin, Colin Havenar-Daughton, et al.
Science Translational Medicine|September 8, 2017
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challengeBoris Julg, Lawrence J Tartaglia, Brandon F Keele, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Virus glycoprotein nanodisc platform for vaccine designKimmo Rantalainen, Alessia Liguori, Gabriel Ozorowski, et al.
Nature Microbiology|November 15, 2016
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerabilityMarit J van Gils, Tom L G M van den Kerkhof, Gabriel Ozorowski, et al.
Nature Communications|August 3, 2022
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoproteinJelle van Schooten, Elinaz Farokhi, Anna Schorcht, et al.
Cell Reports|November 24, 2016
Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env TrimerColin Havenar-Daughton, Diane G Carnathan, Alba Torrents de la Peña, et al.
Plos Pathogens|November 17, 2022
Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizerJelle van Schooten, Anna Schorcht, Elinaz Farokhi, et al.
Nature Communications|September 6, 2022
Molecular insights into antibody-mediated protection against the prototypic simian immunodeficiency virusFangzhu Zhao, Zachary T Berndsen, Nuria Pedreño-Lopez, et al.
Nature Communications|February 10, 2026
Virus glycoprotein nanodisc platform for vaccine analyticsKimmo Rantalainen, Alessia Liguori, Gabriel Ozorowski, et al.
Pageof 12